IBM's Watson Gains Commercial Acceptance in US

#artificialintelligence 

Double blinded validation study to assess performance of IBM artificial intelligence platform Watson for oncology in comparison with Manipal multidisciplinary tumor board--first study of 638 breast cancer cases.

Duplicate Docs Excel Report

Title
None found

Similar Docs  Excel Report  more

TitleSimilaritySource
None found